• Products
  • Suppliers
  • Sourcing Requests
  • Paracetamol
  • capsule
  • Dexamethasone
  • semaglutide
  • peptides
  • Metformin
  • Ritonavir
  • Ibuprofen
  • Yaan Times Biotech Co., Ltd
  • Changsha Staherb Natural Ingredients Co., Ltd.
  • Biocompounds Pharmaceutical Inc.
  • PURELIFE BIOTECH CO.,LTD.
  • Xi'an Kaixiang Photoelectric Technology Co., Ltd
  • Apollo Healthcare Resources (Singapore)
  • West Bengal Chemical Industries Limited
  • Shanghai UFU Laboratory Equipment Co.,Itd
Post Sourcing Request Exhibition
  • Atox Bio Announces Exercise by BARDA of Next Option Period for NSTI Treatment americanpharmaceuticalreview
    June 20, 2019
    Atox Bio announced the Biomedical Advanced Research and Development Authority (BARDA) has exercised the next option on a performance-based contract with for the development of Reltecimod in patients with Necrotizing Soft Tissue Infections (NSTI).
  • Atox Bio Announces Chief Commercial Officer Appointment americanpharmaceuticalreview
    February 18, 2019

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service